What is Basecamp Vascular?
Basecamp Vascular is a French med-tech company that originated as a spin-off from the Intelligent Robotic Systems Laboratory (ISIR) at Sorbonne University and the Rothschild Foundation Hospital in Paris. The company is dedicated to developing advanced technologies aimed at immediate improvement and future applications within endovascular procedures. Its multidisciplinary team focuses on creating cutting-edge solutions to enhance patient outcomes and procedural efficiency in the vascular space.
How much funding has Basecamp Vascular raised?
Basecamp Vascular has raised a total of $6.4M across 1 funding round:
Series A
$6.4M
Series A (2023): $6.4M with participation from NTI Managers and Forepont Capital Partners
Key Investors in Basecamp Vascular
NTI Managers
NTI Managers is a network of physicians focused on investing in and supporting emerging Medtech companies, particularly in neurotechnology. They provide a unique investment vehicle that leverages clinical expertise to add value to companies.
Forepont Capital Partners
Forepont Capital Partners is a global asset manager specializing in healthcare and life sciences, investing in biotech, medtech, and e-health start-ups in the United States and Europe. They provide scientific, technological, financial, and operational support to their portfolio companies.
What's next for Basecamp Vascular?
With this major enterprise-level funding, Basecamp Vascular is poised for significant expansion and further technological development. The strategic investment will likely fuel research and development efforts, accelerate product commercialization, and potentially broaden the company's market reach. This capital injection positions Basecamp Vascular to further solidify its standing in the competitive med-tech landscape and drive innovation in endovascular treatments.
See full Basecamp Vascular company page
